DK2114903T3 - Bicykliske pyrimidinoner og anvendelser deraf - Google Patents

Bicykliske pyrimidinoner og anvendelser deraf

Info

Publication number: DK2114903T3
Authority: DK; Denmark
Prior art keywords: applications; bicyclic pyrimidinones; pyrimidinones; bicyclic
Prior art date: 2006-12-22

Application number

DK07855368.2T

Other languages

English (en)

Inventor

Eric Dale Jones

Jonathan Alan Victor Coates

David Ian Rhodes

John Joseph Deadman

Nicholas Andrew Vandegraff

Lisa Jane Winfield

Neeranat Thienthong

William Issa

Neil Choi

Katherine Macfarlane

Original Assignee

Avexa Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-22

Filing date

2007-12-21

Publication date

2011-04-18

2006-12-22 Priority claimed from AU2006907283A external-priority patent/AU2006907283A0/en

2007-12-21 Application filed by Avexa Ltd filed Critical Avexa Ltd

2011-04-18 Application granted granted Critical

2011-04-18 Publication of DK2114903T3 publication Critical patent/DK2114903T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK07855368.2T 2006-12-22 2007-12-21 Bicykliske pyrimidinoner og anvendelser deraf DK2114903T3 (da)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
AU2006907283A AU2006907283A0 (en)		2006-12-22	Bicyclic pyrimidinones and uses thereof
AU2007902479A AU2007902479A0 (en)		2007-05-09	Bicyclic pyrimidinones and uses thereof (2)
AU2007903401A AU2007903401A0 (en)		2007-06-25	Bicyclic pyrimidinodes and uses thereof (3)
AU2007904114A AU2007904114A0 (en)		2007-07-31	Bicyclic pyrimidinones and uses thereof (4)
PCT/AU2007/001980 WO2008077188A1 (en)	2006-12-22	2007-12-21	Bicyclic pyrimidinones and uses thereof

Publications (1)

Publication Number	Publication Date
DK2114903T3 true DK2114903T3 (da)	2011-04-18

Family

ID=39562030

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07855368.2T DK2114903T3 (da)	2006-12-22	2007-12-21	Bicykliske pyrimidinoner og anvendelser deraf

Country Status (15)

Country	Link
US (3)	US8143268B2 (da)
EP (2)	EP2114903B1 (da)
JP (2)	JP5208962B2 (da)
KR (2)	KR20090097194A (da)
CN (1)	CN101880280B (da)
AR (2)	AR064517A1 (da)
AT (1)	ATE496898T1 (da)
AU (2)	AU2007336703B9 (da)
BR (2)	BRPI0720564A2 (da)
CA (1)	CA2673183C (da)
DE (1)	DE602007012308D1 (da)
DK (1)	DK2114903T3 (da)
MX (1)	MX2009006764A (da)
NZ (1)	NZ577491A (da)
WO (1)	WO2008077188A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2247601T3 (pl) *	2008-07-02	2013-09-30	Avexa Ltd	Tiazopirymidynony i ich zastosowanie
JP5592360B2 (ja) *	2008-07-02	2014-09-17	アベキサ・リミテッド	イミダゾピリミジノンおよびその使用
BRPI0913934A2 (pt) *	2008-07-02	2015-10-20	Avexa Ltd	compostos tendo propriedades antivirais
CN102336751A (zh) *	2010-07-16	2012-02-01	爱维艾珂瑟有限公司	新型抗病毒剂
JP6448647B2 (ja)	2013-09-12	2019-01-09	アリオスバイオファーマインク．	アザ−ピリドン化合物およびその用途
US10195202B2 (en)	2013-12-19	2019-02-05	Ptc Therapeutics, Inc.	Methods for modulating the amount of RNA transcripts
MX383931B (es)	2015-03-11	2025-03-14	Janssen Biopharma Inc	Compuestos de aza-piridona y usos de estos.
EP3310169B1 (en)	2015-05-30	2023-05-17	PTC Therapeutics, Inc.	Methods for modulating rna splicing
CN108697709A (zh)	2015-12-10	2018-10-23	Ptc医疗公司	用于治疗亨廷顿病的方法
AU2017363369A1 (en)	2016-11-28	2019-05-30	Ptc Therapeutics, Inc	Methods for modulating RNA splicing
AU2018282154B2 (en)	2017-06-05	2022-04-07	Ptc Therapeutics, Inc.	Compounds for treating huntington's disease
US11608501B2 (en)	2017-06-14	2023-03-21	Ptc Therapeutics, Inc.	Methods for modifying RNA splicing
CN111182898B (zh)	2017-06-28	2024-04-16	Ptc医疗公司	用于治疗亨廷顿氏病的方法
WO2019005993A1 (en)	2017-06-28	2019-01-03	Ptc Therapeutics, Inc.	METHODS OF TREATING HUNTINGTON'S DISEASE
BR112020019373A2 (pt)	2018-03-27	2020-12-29	Ptc Therapeutics, Inc.	Compostos para o tratamento da doença de hutington
IL279688B2 (en)	2018-06-27	2025-01-01	Ptc Therapeutics Inc	Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
EP3814360B8 (en)	2018-06-27	2024-11-06	PTC Therapeutics, Inc.	Heteroaryl compounds for treating huntington's disease
WO2020005877A1 (en)	2018-06-27	2020-01-02	Ptc Therapeutics, Inc.	Heteroaryl compounds for treating huntington's disease
AU2020394867A1 (en)	2019-12-02	2022-05-26	Storm Therapeutics Limited	Polyheterocyclic compounds as METTL3 inhibitors
US12070445B2 (en) *	2021-08-27	2024-08-27	Wisconsin Alumni Research Foundation	System and assay for monitoring production/release of membrane-lytic toxins in bacteria and compounds for modulating same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002241459A1 (en)	2000-09-20	2002-06-11	Schering Corporation	Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
AR042095A1 (es)	2002-11-20	2005-06-08	Japan Tobacco Inc	Compuesto 4-oxoquinolina y aplicacion del mismo como inhibidor de integrasa de vih
DK1697343T3 (da)	2003-12-18	2009-10-05	Tibotec Pharm Ltd	Aminobenzimidazoler og benzimidazoler som inhibitorer af replikation af respiratorisk syncytialvirus
TW200526635A (en) *	2003-12-22	2005-08-16	Shionogi & Co	Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
AU2005293336B2 (en)	2004-10-12	2009-05-28	Astrazeneca Ab	Quinazoline derivatives
CN101146811B (zh) *	2005-03-31	2012-01-11	P.安杰莱蒂分子生物学研究所	Hiv整合酶抑制剂
EP1937678B1 (en) *	2005-10-04	2011-07-27	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Hiv integrase inhibitors

2007
- 2007-12-21 WO PCT/AU2007/001980 patent/WO2008077188A1/en not_active Ceased
- 2007-12-21 JP JP2009541695A patent/JP5208962B2/ja not_active Expired - Fee Related
- 2007-12-21 EP EP07855368A patent/EP2114903B1/en active Active
- 2007-12-21 NZ NZ577491A patent/NZ577491A/en not_active IP Right Cessation
- 2007-12-21 BR BRPI0720564-3A patent/BRPI0720564A2/pt not_active IP Right Cessation
- 2007-12-21 CN CN201010148170.6A patent/CN101880280B/zh not_active Expired - Fee Related
- 2007-12-21 AU AU2007336703A patent/AU2007336703B9/en not_active Ceased
- 2007-12-21 KR KR1020097014886A patent/KR20090097194A/ko not_active Ceased
- 2007-12-21 BR BRPI0722411-7A patent/BRPI0722411A2/pt active Search and Examination
- 2007-12-21 EP EP10164218A patent/EP2269992A1/en not_active Withdrawn
- 2007-12-21 DK DK07855368.2T patent/DK2114903T3/da active
- 2007-12-21 US US12/519,273 patent/US8143268B2/en not_active Expired - Fee Related
- 2007-12-21 MX MX2009006764A patent/MX2009006764A/es active IP Right Grant
- 2007-12-21 AR ARP070105884A patent/AR064517A1/es not_active Application Discontinuation
- 2007-12-21 AT AT07855368T patent/ATE496898T1/de not_active IP Right Cessation
- 2007-12-21 CA CA2673183A patent/CA2673183C/en not_active Expired - Fee Related
- 2007-12-21 DE DE602007012308T patent/DE602007012308D1/de active Active
- 2007-12-21 KR KR1020107008711A patent/KR20100049698A/ko not_active Ceased
2010
- 2010-03-24 AU AU2010201160A patent/AU2010201160A1/en not_active Abandoned
- 2010-04-23 US US12/766,510 patent/US8207334B2/en not_active Expired - Fee Related
- 2010-06-07 JP JP2010129801A patent/JP2010222370A/ja not_active Withdrawn
- 2010-06-09 AR ARP100102037A patent/AR077043A2/es unknown
2012
- 2012-02-27 US US13/405,511 patent/US8859563B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HK1131615A1 (en)	2010-01-29
AU2007336703B2 (en)	2012-04-12
AR077043A2 (es)	2011-07-27
JP5208962B2 (ja)	2013-06-12
EP2114903A1 (en)	2009-11-11
US8143268B2 (en)	2012-03-27
CA2673183A1 (en)	2008-07-03
AU2010201160A1 (en)	2010-04-15
CN101880280A (zh)	2010-11-10
EP2114903A4 (en)	2009-12-30
CN101880280B (zh)	2014-07-16
AU2007336703A1 (en)	2008-07-03
BRPI0722411A2 (pt)	2012-06-05
AR064517A1 (es)	2009-04-08
ATE496898T1 (de)	2011-02-15
EP2269992A1 (en)	2011-01-05
JP2010222370A (ja)	2010-10-07
US20100168063A1 (en)	2010-07-01
KR20100049698A (ko)	2010-05-12
US20110009366A1 (en)	2011-01-13
BRPI0720564A2 (pt)	2011-08-16
US8207334B2 (en)	2012-06-26
WO2008077188A1 (en)	2008-07-03
MX2009006764A (es)	2009-11-26
US8859563B2 (en)	2014-10-14
DE602007012308D1 (de)	2011-03-10
CA2673183C (en)	2014-06-10
NZ577491A (en)	2011-06-30
EP2114903B1 (en)	2011-01-26
JP2010513322A (ja)	2010-04-30
KR20090097194A (ko)	2009-09-15
US20120232035A1 (en)	2012-09-13
AU2007336703B9 (en)	2014-03-27

Publication	Publication Date	Title
DK2114903T3 (da)	2011-04-18	Bicykliske pyrimidinoner og anvendelser deraf
DK2059535T3 (da)	2014-01-13	Prlr-specifikt antistof og anvendelser deraf
DK2209806T3 (da)	2012-09-17	Anti-hepcidin-antistoffer og anvendelser deraf
DK2142529T3 (da)	2014-02-10	Trpv1-antagonister og anvendelser deraf
DK1767815T3 (da)	2011-02-07	Reduktionsgear
DK2147096T3 (da)	2015-06-15	Modificerede faktor-VII-polypeptider og anvendelser deraf
BRPI0812367A2 (pt)	2015-02-03	Dispositivos interoclusais e respectivos métodos de fabrico
DK2068887T3 (da)	2014-05-19	SP35-antistoffer og anvendelser heraf
DK2118140T3 (da)	2013-07-01	Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DK2170827T3 (da)	2013-11-18	Indolin-2-oner og aza-indolin-2-oner
BRPI0716300A2 (pt)	2014-02-25	Artigo e mistura
DK2012773T3 (da)	2012-09-24	Lægemidler og anvendelser deraf
DK1866339T3 (da)	2013-09-02	GTR-bindende molekyler og anvendelser heraf
PT2537529T (pt)	2018-12-12	Anticorpos inibidores de loxl2 e suas utilizações
DK2139490T3 (da)	2014-09-08	Diazo-bicykliske smac-mimetiske stoffer og anvendelser deraf
NO20085030L (no)	2009-01-06	Pyrrolopyrimidinforbindelser og deres anvendelser
DK1994055T3 (da)	2014-08-25	Anti-5t4-antistoffer og anvendelser deraf
DE502006006338D1 (de)	2010-04-15	Ächen
BRPI0719369A2 (pt)	2014-02-04	Porta-prótese e aplicações do mesmo
EP2113133A4 (en)	2011-09-07	ELECTROLUMINESCENT ELEMENT, ELECTROLUMINESCENT DEVICE, ELECTRONIC DEVICE AND QUINOXALIN DERIVED THEREOF
DK2001556T3 (da)	2014-11-10	Thioninium-forbindelser og anvendelse deraf
DK1894567T3 (da)	2012-11-19	Ledsagende farmaceutiske midler og anvendelse deraf
DK2079485T3 (da)	2012-08-06	Phenylpropionamidforbindelser og anvendelsen deraf
EP2209114A4 (en)	2011-09-28	ENCODER AND DECODER
DK2185175T3 (da)	2013-05-13	MMP-9-regulatorer og anvendelser deraf